Colorado Cancer Research Prgrm entered the industry of Medical Research in 2006 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417112, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Jane Hajovsky, Executive Director by calling (303) 777-2663 during business hours. You can also write to the business’ Single Location at 1720 South Bellaire St # 701, Denver, Colorado CO 80222. You can also visit the company’s website at co-cancerresearch.org. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Colorado Cancer Research Prgrm |
Representative: | Jane Hajovsky, Executive Director |
Place of Business: | 1720 South Bellaire St # 701, Denver, CO 80222 |
Contact Number: | (303) 777-2663 |
Website: | co-cancerresearch.org |
Type of Service: | Medical Research |
SIC Number: | 8733 |
NAICS Number: | 5417112 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2006 |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Colorado Cancer Research Prgrm is a company operating from Denver, Colorado providing professional Medical Research and relevant B2B variables. It was founded in 2006 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 5417112 as Medical Research.
With a current employee count of 1 to 4, Colorado Cancer Research Prgrm has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Jane Hajovsky, Executive Director at (303) 777-2663 for related queries, or to locate its Single Location using the coordinates 39.6854,-104.937255.
The Single Location can also be found at the street address 1720 South Bellaire St # 701 in Denver, Colorado 80222 and can be engaged online through the company website at co-cancerresearch.org, the company Twitter , and Facebook page .